Home/Filings/4/0001209191-21-017256
4//SEC Filing

KELLEY SCOTT 4

Accession 0001209191-21-017256

CIK 0001419600other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:29 PM ET

Size

7.3 KB

Accession

0001209191-21-017256

Insider Transaction Report

Form 4
Period: 2021-03-01
KELLEY SCOTT
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-03-01+30,000143,549 total
  • Award

    Stock option (right to buy)

    2021-03-01+20,00020,000 total
    Exercise: $11.41Exp: 2031-02-28Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
  • [F2]25% of the shares shall vest on the one-year anniversary of January 1, 2021 (the "Vesting Commencement Date"), and thereafter 1/48th of the total shares shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four years after the Vesting Commencement Date.

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeother

Related Parties

1
  • filerCIK 0001222950

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:29 PM ET
Size
7.3 KB